Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
Tommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo
Clin Mol Hepatol. 2019;25(4):360-365.   Published online 2019 May 2     DOI: https://doi.org/10.3350/cmh.2019.0022
Citations to this article as recorded by Crossref logo
Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries
Caroline E Boeke, Lindsey Hiebert, Imam Waked, Tengiz Tsertsvadze, Lali Sharvadze, Maia Butsashvili, Mamuka Zakalashvili, Win Naing, Neil Gupta, Fredrick Kateera, Craig McClure, John W Ward, Christian B Ramers
Clinical Infectious Diseases.2022; 74(3): 513.     CrossRef
Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
Iman Ibrahim Salama, Hala M Raslan, Ghada A Abdel-Latif, Somaia I Salama, Samia M Sami, Fatma A Shaaban, Aida M Abdelmohsen, Walaa A Fouad
World Journal of Hepatology.2022; 14(6): 1053.     CrossRef
Drug-drug interactions with direct-acting antivirals — less is more
Grace Lai-Hung Wong
Clinical and Molecular Hepatology.2021; 27(1): 81.     CrossRef
Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting Antivirals
Naglaa S Elabd, Safaa I Tayel, Moamena S Elhamouly, Shaimaa A Hassanein, Samar M Kamaleldeen, Fatma E Ahmed, Mahmoud Rizk, Abdelnaser A Gadallah, Soma E Ajlan, Ahmed S Sief
Hepatic Medicine: Evidence and Research.2021; Volume 13: 9.     CrossRef
Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?
Virginia Solitano, Maria Corina Plaz Torres, Nicola Pugliese, Alessio Aghemo
Viruses.2021; 13(6): 1048.     CrossRef
Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals
Pil Soo Sung, Eui-Cheol Shin
International Journal of Molecular Sciences.2020; 21(7): 2583.     CrossRef
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Chung-Feng Huang, Ming-Lung Yu
Clinical and Molecular Hepatology.2020; 26(3): 251.     CrossRef
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
Hye Won Lee, Dai Hoon Han, Hye Jung Shin, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2020; 12(11): 3414.     CrossRef